The scientific quest for lasting youth: Prospects for curing aging

Rejuvenation Research

Volumn 17, Issue 5, 2014, Pages 458-467

  De Magalhães, João Pedro ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; AGING; ARTICLE; CANCER THERAPY; ETHICS; GENE THERAPY; GENETIC CODE; GENETIC MANIPULATION; GENOMIC INSTABILITY; GENOMICS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN GENOME; INFORMATION SCIENCE; JUVENILE; LIFE EXPECTANCY; LIFE EXTENSION; LONGEVITY; MEDICAL RESEARCH; MESENCHYMAL STEM CELL; MOTIVATION; MUSCLE REGENERATION; NONHUMAN; PERSONALIZED MEDICINE; REGENERATIVE MEDICINE; SYNTHETIC BIOLOGY; BIOENGINEERING; PHYSIOLOGY; REJUVENATION;

AGING; HUMAN ENGINEERING; HUMANS; LONGEVITY; REGENERATIVE MEDICINE; REJUVENATION;

EID: 84912002247     PISSN: 15491684     EISSN: 15578577     Source Type: Journal    
DOI: 10.1089/rej.2014.1580     Document Type: Article

References (89)

1. Cave S. Immortality: The Quest to Live Forever and How It Drives Civilization. Crown, New York, 2012.
2. Ettinger R. The Prospect of Immortality. Doubleday, New York, 1964.
3. de Grey A, Rae M. Ending Aging: The Rejuvenation Breakthroughs That Could Reverse Human Aging in Our Lifetime. St. Martin's Press, New York, 2008.
4. de Grey AD, Ames BN, Andersen JK, Bartke A, Campisi J, Heward CB, McCarter RJM, Stock G. Time to talk SENS: Critiquing the immutability of human aging. Ann NY Acad Sci 2002;959:452-462; discussion 463-455.
5. Kurzweil R, Grossman T. Fantastic Voyage: Live Long Enough to Live Forever. Rodale, Emmaus, PA, 2004.
6. Warner H, Anderson J, Austad S, Bergamini E, Bredesen D, Butler R, Carnes BA, Clark BFC, Cristofalo V, Faulkner J, Guarente L, Harrison DE, Kirkwood T, Lithgow G, Martin G, Masoro E, Melov S, Miller RA, Olshansky SJ, Partridge L, Pereira-Smith O, Perls T, Richardson A, Smith J, von Zglinicki T, Wang E, Wei JY, FranklinWilliams TF. Science fact and the SENS agenda. What can we reasonably expect from ageing research? EMBO Rep 2005;6:1006-1008.
7. Holliday R. The extreme arrogance of anti-aging medicine. Biogerontology 2009;10:223-228.
8. Warner HR. Scientific and ethical concerns regarding engineering human longevity. Rejuvenation Res 2006;9:440-442; discussion 443-445.
9. Olshansky SJ, Carnes BA. Zeno's paradox of immortality. Gerontology 2013;59:85-92.
10. Vijg J, Campisi J. Puzzles, promises and a cure for ageing. Nature 2008;454:1065-1071.
11. Abramovich A, Muradian KK, Fraifeld VE. Have we reached the point for in vivo rejuvenation? Rejuvenation Res; 11(2):489-492.
12. Institute I, ed The Dream of Elixir Vitae. The Scientific Conquest of Death: Essays on Infinite Lifespans.Libros En Red, Buenos Aires, 2004.
13. Sethe S, de Magalhães JP. Ethical perspectives in biogerontology. In: Schermer M, Pinxten W, eds. Ethics, Health Policy and (Anti-) Aging: Mixed Blessings. Springer, Dordrecht, Netherlands, 2013, pp. 173-188.
14. Vijg J, de Grey AD. Innovating aging: Promises and pitfalls on the road to life extension. Gerontology 2014;60:373-380.
15. Hayflick L. "Anti-aging" is an oxymoron. J Gerontol A Biol Sci Med Sci 2004;59:B573-B578.
16. Finch CE. Longevity, Senescence, and the Genome. The University of Chicago Press, Chicago and London, 1990.
17. de Magalhães JP. How ageing processes influence cancer. Nat Rev Cancer 2013;13:357-365.
18. Herculano-Houzel S. The human brain in numbers: A linearly scaled-up primate brain. Front Hum Neurosci 2009;3:31.
19. Pakkenberg B, Pelvig D, Marner L, Bundgaard MJ, Gundersen HJ, Nyengaard JR, Regeur L. Aging and the human neocortex. Exp Gerontol 2003;38:95-99.
20. Fox JL. $350 million in new funding for brain research. Nat Biotechnol 2013;31:480.
21. Caplan AL. Death as an unnatural process. Why is it wrong to seek a cure for aging? EMBO Rep 2005;6(Spec No.):S72-S75.
22. Harris J. Immortal ethics. Ann NY Acad Sci 2004;1019:527-534.
23. Church G, Regis E. Regenesis: How Synthetic Biology Will Reinvent Nature and Ourselves. Basic Books, New York, 2012.
24. de Magalhães JP, Wuttke D, Wood SH, Plank M, Vora C. Genome-environment interactions that modulate aging: powerful targets for drug discovery. Pharmacol Rev 2012;64:88-101.
25. Kenyon CJ. The genetics of ageing. Nature 2010;464:504-512.
26. Tacutu R, Craig T, Budovsky A, Wuttke D, Lehmann G, Taranukha D, Costa J, Fraifeld VE, and de Magalhães JP. Human Ageing Genomic Resources: Integrated databases and tools for the biology and genetics of ageing. Nucleic Acids Res 2013;41:D1027-D1033.
27. Ayyadevara S, Alla R, Thaden JJ, Shmookler Reis RJ. Remarkable longevity and stress resistance of nematode PI3K-null mutants. Aging Cell 2008;7:13-22.
28. Pew Research Center. Living to 120 and Beyond: Americans' Views on Aging, Medical Advances and Radical Life Extension. 2013. Available at www.pewforum.org/2013/08/06/living-to-120-and-beyond-americans-views-on-aging-medical-advances-and-radical-life-extension/
29. Stipp D. The Youth Pill: Scientists at the Brink of an Anti-Aging Revolution. Penguin Books, London, 2010.
30. de Magalhães JP. Why genes extending lifespan in model organisms have not been consistently associated with human longevity and what it means to translation research. Cell Cycle 2014;13:2671-2673.
31. Mattison JA, Roth GS, Beasley TM, Tilmont EM, Handy AH, Herbert RL, Longo DL, Allison DB, Young JE, Bryant M, Barnard D, Ward WF, Qi W, Ingram DK, l de Cabo R. Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study. Nature 2012;489:318-321.
32. Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell 2013;153:1194-1217.
33. Freitas AA, de Magalhães JP. A review and appraisal of the DNA damage theory of ageing. Mutat Res 2011;728:12-22.
34. de Magalhães JP. The biology of ageing: A primer. In: Stuart-Hamilton I, ed. An Introduction to Gerontology. Cambridge University Press, Cambridge, UK, 2011, pp. 21-47.
35. de Magalhães JP, Toussaint O. Telomeres and telomerase: A modern fountain of youth? Rejuvenation Res 2004;7:126-133.
36. Unal E, Kinde B, Amon A. Gametogenesis eliminates ageinduced cellular damage and resets life span in yeast. Science 2011;332:1554-1557.
37. DiMasi JA, Feldman L, Seckler A, Wilson A. Trends in risks associated with new drug development: Success rates for investigational drugs. Clin Pharmacol Ther 2010;87:272-277.
38. Plenge RM, Scolnick EM, Altshuler D. Validating therapeutic targets through human genetics. Nat Rev Drug Discov 2013;12:581-594.
39. Heinemann M, Panke S. Synthetic biology-putting engineering into biology. Bioinformatics 2006;22:2790-2799.
40. Slusarczyk AL, Lin A, Weiss R. Foundations for the design and implementation of synthetic genetic circuits. Nat Rev Genet 2012;13:406-420.
41. Ruder WC, Lu T, Collins JJ. Synthetic biology moving into the clinic. Science 2011;333:1248-1252.
42. Weber W, Fussenegger M. Emerging biomedical applications of synthetic biology. Nat Rev Genet 2012;13:21-35.
43. Wood SH, Craig T, Li Y, Merry B, de Magalhães JP. Whole transcriptome sequencing of the aging rat brain reveals dynamic RNA changes in the dark matter of the genome. Age (Dordr) 2013;35:763-776.
44. de Magalhães JP, Finch CE, Janssens G. Next-generation sequencing in aging research: Emerging applications, problems, pitfalls and possible solutions. Ageing Res Rev 2010;9:315-323.
45. Collins FS, Rossant J, Wurst W. A mouse for all reasons. Cell 2007;128:9-13.
46. Morgan H, Beck T, Blake A, Richardson D, Wells S, White J, Wood J, The EUMODIC Consortium, Martin Hrabé de Angelis, Brown SDM, Hancock JM, Mallon A-M.Euro-Phenome: A repository for high-throughput mouse phenotyping data. Nucleic Acids Res 2010;38(database issue):D577-D585.
47. Bassik MC, Kampmann M, Lebbink RJ, Wang S, Hein MY, Poser I, Weibezahn J, Horlbeck MA, Chen S, Mann M, Hyman AA, LeProust EM, McManus MT, Weissman JS. A systematic mammalian genetic interaction map reveals pathways underlying ricin susceptibility. Cell 2013;152:909-922.
48. Plank M, Hu G, Silva AS, Wood SH, Hesketh EE, Janssens G, Macedo A, de Magalhães JP, Church GM. An analysis and validation pipeline for large-scale RNAi-based screens. Sci Rep 2013;3:1076.
49. Schlabach MR, Luo J, Solimini NL, Hu G, Xu Q, Li MZ, Zhao Z, Smogorzewska A, Sowa ME, Ang XL, Westbrook TF, Liang AC, Chang K, Hackett JA, Harper JW, Hannon GJ, Elledge SJ. Cancer proliferation gene discovery through functional genomics. Science 2008;319:620-624.
50. Dunham I, Kundaje A, Aldred SF, et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012;489:57-74.
51. Stamatoyannopoulos JA. What does our genome encode? Genome Res 2012;22:1602-1611.
52. Head start. Nature 2013;503:5.
53. Lounkine E, Keiser MJ, Whitebread S, Mikhailov D, Hamon J, Jenkins J, Lavan P, Weber E, Doak AK, Côté S, Shoichet BK, Urban L. Large-scale prediction and testing of drug activity on side-effect targets. Nature 2012;486:361-367.
54. Zhang QC, Petrey D, Deng L, Qiang L, Shi Y, Thu CA, Bisikirska B, Lefebvre C, Accili D, Hunter T, Maniatis T, Califano A, Honig B. Structure-based prediction of proteinprotein interactions on a genome-wide scale. Nature 2012;490:556-560.
55. Wilczynski B, Liu YH, Yeo ZX, Furlong EE. Predicting spatial and temporal gene expression using an integrative model of transcription factor occupancy and chromatin state. PLoS Comput Biol 2012;8:e1002798.
56. Karr JR, Sanghvi JC, Macklin DN, Gutschow MV, Jacobs JM, Bolival B Jr, Assad-Garcia N, Glass JI, Covert MW. A whole-cell computational model predicts phenotype from genotype. Cell 2012;150:389-401.
57. de Magalhães JP. Aging research in the post-genome era: New technologies for an old problem. In: Foyer CH, Faragher R, Thornalley PJ, eds. Redox Metabolism and Longevity Relationships in Animals and Plants. Taylor and Francis, New York and Abingdon, 2009, pp. 99-115.
58. Tacutu R, Shore DE, Budovsky A, de Magalhães JP, Ruvkun G, Fraifeld VE, Curran SP. Prediction of C. elegans longevity genes by human and worm longevity networks. PloS One 2012;7:e48282.
59. Wuttke D, Connor R, Vora C, Craig T, Li Y, Wood S, Vasieva O, Reis RS, Tang F, de Magalhães JP. Dissecting the gene network of dietary restriction to identify evolutionarily conserved pathways and new functional genes. PLoS Genet 2012;8:e1002834.
60. van Dam S, Cordeiro R, Craig T, van Dam J, Wood SH, de Magalhães JP. GeneFriends: An online co-expression analysis tool to identify novel gene targets for aging and complex diseases. BMC Genomics 2012;13:535.
61. Garcia-Cao I, Garcia-Cao M, Martin-Caballero J, Criado LM, Klatt P, Flores JM, Weill J-C, Blasco MA, Serrano M. "Super p53" mice exhibit enhanced DNA damage response, are tumor resistant and age normally. EMBO J 2002;21:6225-6235.
62. Matheu A, Pantoja C, Efeyan A, Criado LM, Martin- Caballero J, Flores JM, Klatt P, Serrano M. Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging. Genes Dev 2004;18:2736-2746.
63. Brazil R. Venter to sequence longevity. Nature Biotech 2014;32:406.
64. Hood L, Price ND. Demystifying disease, democratizing health care. Sci Translat Med 2014;6:225ed225.
65. Friend SH, Schadt EE. Translational genomics. Clues from the resilient. Science 2014;344:970-972.
66. Reyon D, Tsai SQ, Khayter C, Foden JA, Sander JD, Joung JK. FLASH assembly of TALENs for high-throughput genome editing. Nat Biotech 2012;30:460-465.
67. Wang J, Friedman G, Doyon Y, Wang NS, Li CJ, Miller JC, Hua KL, Yan JJ, Babiarz JE, Gregory PD, Holmes MC. Targeted gene addition to a predetermined site in the human genome using a ZFN-based nicking enzyme. Genome Res 2012;22:1316-1326.
68. Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM. RNA-guided human genome engineering via Cas9. Science 2013;339:823-826.
69. Wang J, Geesman GJ, Hostikka SL, Atallah M, Blackwell B, Lee E, Cook PJ, Pasaniuc B, Shariat G, Halperin E, Dobke M, Rosenfeld MG, Jordan IK, Lunyak VV. Inhibition of activated pericentromeric SINE/Alu repeat transcription in senescent human adult stem cells reinstates self-renewal. Cell Cycle 2011;10:3016-3030.
70. - memory T cells. J Immunol 2011;187:2093-2100.
71. Bredenkamp N, Nowell CS, Blackburn CC. Regeneration of the aged thymus by a single transcription factor. Development 2014;141:1627-1637.
72. Lapasset L, Milhavet O, Prieur A, Besnard E, Babled A, Aït-Hamou N, Leschik J, Pellestor F, Ramirez JM, De Vos J, Lehmann S, Lemaitre JM. Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state. Genes Dev 2011;25:2248-2253.
73. Han J, Mistriotis P, Lei P, Wang D, Liu S, Andreadis ST. Nanog reverses the effects of organismal aging on mesenchymal stem cell proliferation and myogenic differentiation potential. Stem Cells 2012;30:2746-2759.
74. Wahlestedt M, Norddahl GL, Sten G, Ugale A, Frisk MA, Mattsson R, Deierborg T, Sigvardsson M, Bryder D. An epigenetic component of hematopoietic stem cell aging amenable to reprogramming into a young state. Blood 2013;121:4257-4264.
75. Rando TA, Chang HY. Aging, rejuvenation, and epigenetic reprogramming: Resetting the aging clock. Cell 2012;148:46-57.
76. Mason JB, Cargill SL, Anderson GB, Carey JR. Transplantation of young ovaries to old mice increased life span in transplant recipients. J Gerontol A Biol Sci Med Sci 2009;64:1207-1211.
77. Carlson ME, Hsu M, Conboy IM. Imbalance between pSmad3 and Notch induces CDK inhibitors in old muscle stem cells. Nature 2008;454:528-532.
78. Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, Bieri G, Stan TM, Fainberg N, Ding Z, Eggel A, Lucin KM, Czirr E, Park JS, Couillard-Després S, Aigner L, Li G, Peskind ER, Kaye JA, Quinn JF, Galasko DR, Xie XS, Rando TA, Wyss-Coray T. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 2011;477:90-94.
79. Li H, Haurigot V, Doyon Y, Li T, Wong SY, Bhagwat AS, Malani N, Anguela XM, Sharma R, Ivanciu L, Murphy SL, Finn JD, Khazi FR, Zhou S, Paschon DE, Rebar EJ, Bushman FD, Gregory PD, Holmes MC, High KA. In vivo genome editing restores haemostasis in a mouse model of haemophilia. Nature 2011;475:217-221.
80. Hwu WL, Muramatsu S, Tseng SH, Tzen KY, Lee NC, Chien YH, Snyder RO, Byrne BJ, Tai CH, Wu RM. Gene therapy for aromatic L-amino acid decarboxylase deficiency. Sci Transl Med 2012;4:134ra161.
81. Yu D, Pendergraff H, Liu J, Kordasiewicz HB, Cleveland DW, Swayze EE, Lima WF, Crooke ST, Prakash TP, Corey DR. Single-stranded RNAs use RNAi to potently and allele-selectively inhibit mutant huntingtin expression. Cell 2012;150:895-908.
82. Shen J, Tsai YT, Dimarco NM, Long MA, Sun X, Tang L. Transplantation of mesenchymal stem cells from young donors delays aging in mice. Sci Rep 2011;1:67.
83. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676.
84. Ginn SL, Alexander IE, Edelstein ML, Abedi MR, Wixon J. Gene therapy clinical trials worldwide to 2012-an update. J Gene Med 2013;15:65-77.
85. Garber K. Inducing translation. Nat Biotech 2013;31:483-486.
86. Lakdawalla DN, Sun EC, Jena AB, Reyes CM, Foldman DP, Philipson TJ. An economic evaluation of the war on cancer. J Health Econ 2010;29:333-346.
87. Haber DA, Gray NS, Baselga J. The evolving war on cancer. Cell 2011;145:19-24.
88. de Magalhães JP. The dream of elixir vitae. In: Immortality Institute, ed. The Scientific Conquest of Death: Essays on Infinite Lifespans. Libros En Red, Buenos Aires, 2004, pp. 47-62.
89. Brenner S. History of science. The revolution in the life sciences. Science 2012;338:1427-1428.